Ergam Lifesciences was established in 2012 and promoted by a team of highly qualified professionals with academic & industrial experience, involved in active research & setting up greenfield projects. It emerged as Contract Research Organization (CRO), and API’s intermediates and fine chemicals and custom synthesis that manufactures and delivers the novel synthetic intermediates on competitive cost basis. We have significant laboratory facilities and experienced man power which enable to optimize novel synthetic routes to target intermediates developing the process wherever necessary.
To manufacture and market affordable intermediates that comply with global standards and to achieve market leadership in domestic as well as international markets.
The quality policy of Ergam Lifesciences stands committed to Current Good Manufacturing Practices, conforming to International Standards, ensuring timely supply with cost effectiveness.
Quality pharmaceutical products to meet customers’ expectations, achieving high customer satisfaction and market leadership in domestic as well as overseas markets by implementing Quality Management Systems on continual improvement basis.